OLD National Bancorp IN Reduces Stock Position in Humana Inc. $HUM

OLD National Bancorp IN reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 25.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,788 shares of the insurance provider’s stock after selling 616 shares during the quarter. OLD National Bancorp IN’s holdings in Humana were worth $437,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of HUM. Cary Street Partners Investment Advisory LLC increased its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 46 shares during the period. Garde Capital Inc. bought a new stake in Humana during the 1st quarter worth approximately $36,000. Zions Bancorporation National Association UT bought a new stake in Humana during the 1st quarter worth approximately $37,000. Ransom Advisory Ltd bought a new stake in Humana during the 1st quarter worth approximately $66,000. Finally, Rakuten Securities Inc. increased its holdings in Humana by 50.0% during the 1st quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider’s stock worth $79,000 after acquiring an additional 100 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

HUM stock opened at $295.26 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The firm’s fifty day moving average is $277.31 and its 200 day moving average is $257.76. The firm has a market cap of $35.51 billion, a P/E ratio of 22.66, a P/E/G ratio of 1.73 and a beta of 0.42.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the business posted $6.96 EPS. Humana’s revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s dividend payout ratio (DPR) is currently 27.17%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on HUM shares. Barclays decreased their target price on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating on the stock in a report on Friday. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a report on Saturday, September 27th. Sanford C. Bernstein upped their target price on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Robert W. Baird decreased their price target on shares of Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Finally, Piper Sandler decreased their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Seven research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $293.50.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.